| Trial ID: | L7003 |
| Source ID: | NCT00282945
|
| Associated Drug: |
Rosiglitazone
|
| Title: |
Beta Cell Function Tests Over Time In Patients With T2dm Randomized To Metformin Or Rosiglitazone
|
| Acronym: |
|
| Status: |
TERMINATED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus
|
| Interventions: |
DRUG: Rosiglitazone|DRUG: Metformin
|
| Outcome Measures: |
Primary: This study will examine whether biomarkers of B-cell function measured early in the study (1, 3, and/or 6 months) will predict long-term changes in B-cell function (as represented by HOMA-B). |
|
| Sponsor/Collaborators: |
Sponsor: Pfizer
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
29
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: DIAGNOSTIC
|
| Start Date: |
2006-01
|
| Completion Date: |
2007-10
|
| Results First Posted: |
|
| Last Update Posted: |
2008-10-13
|
| Locations: |
Pfizer Investigational Site, Holon, 58100, Israel|Pfizer Investigational Site, Jerusalem, 91120, Israel
|
| URL: |
https://clinicaltrials.gov/show/NCT00282945
|
